24/7 Wall St2h
Eli Lilly (LLY) Stock Price Prediction and Forecast 2025-2030
Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart has been straight up and to the right, up 501.82% and ...
Elon Musk says he prefers Lilly’s Mounjaro over Novo’s Ozempic
CEO's use of Eli Lilly's (LLY) weight loss drug Mounjaro over Novo Nordisk's (NVO) rival product, Ozempic. Read more here.
World’s Richest Man Elon Musk Reveals The Drug He Takes To Lose Weight
A slim-looking Elon Musk in a Santa suit with a revelation has set the social media on fire. Musk, the richest man in the world with a net worth of more than 470 billion Dollars, revealed that he ...
Not just fat loss, weight loss drugs are causing bone and muscle loss too: What it means
Weight loss drugs like Wegovy, Ozempic, and Mounjaro show transformative effects in obesity, improving heart health and ...
‘An insatiable itch’: Why some people are turning to weight-loss medications to help quiet food noise
Savannah Mendoza used to spend most of her paychecks on food delivery apps and at fast food drive-thrus, trying to satisfy a ...
Kenosha News6h
Jury finds local pastor not guilty of allegations of sexual assault
A Kenosha County jury has found Monroe Mitchell III, the pastor of Agape Love Christian Ministries, Inc. not guilty of sexual ...
McKnight's Long-Term Care News8h
FDA approves Zepbound for sleep apnea in patients with obesity
The US Food and Drug Administration has approved Zepbound (tirzepatide) as the first prescription medication for the treatment of obstructive sleep apnea (OSA).
The Spokesman-Review16h
FDA approves weight-loss drug Zepbound to treat sleep apnea
The FDA first approved Zepbound to treat obesity in November 2023. Its active ingredient, tirzepatide, was previously ...
FDA approves first medication for obstructive sleep apnea — which also promotes weight loss
The first medication for obstructive sleep apnea has been approved by the US Food and Drug Administration (FDA).